Roberta Mazzieri

6.8k total citations · 2 hit papers
60 papers, 5.2k citations indexed

About

Roberta Mazzieri is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Roberta Mazzieri has authored 60 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Immunology and 20 papers in Oncology. Recurrent topics in Roberta Mazzieri's work include Protease and Inhibitor Mechanisms (15 papers), Immune cells in cancer (9 papers) and Immunotherapy and Immune Responses (8 papers). Roberta Mazzieri is often cited by papers focused on Protease and Inhibitor Mechanisms (15 papers), Immune cells in cancer (9 papers) and Immunotherapy and Immune Responses (8 papers). Roberta Mazzieri collaborates with scholars based in Australia, Italy and United States. Roberta Mazzieri's co-authors include Daniel B. Rifkin, Luigi Naldini, John S. Munger, Paolo Mignatti, Pierre‐Emmanuel Gleizes, Davide Moi, Erika Zonari, Ferdinando Pucci, Michele De Palma and John G. Harpel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Roberta Mazzieri

59 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

2011 489 citations Roberta Mazzieri, Ferdinando Pucci et al. Cancer Cell profile →
Targeted genome editing in human repopulating haematopoietic stem cells

2014 434 citations Pietro Genovese, Giulia Schiroli et al. Nature profile →

Peers

Countries citing papers authored by Roberta Mazzieri

Since Specialization

Citations

This map shows the geographic impact of Roberta Mazzieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Mazzieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Mazzieri more than expected).

Fields of papers citing papers by Roberta Mazzieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Mazzieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Mazzieri. The network helps show where Roberta Mazzieri may publish in the future.

Co-authorship network of co-authors of Roberta Mazzieri

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Mazzieri. A scholar is included among the top collaborators of Roberta Mazzieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Mazzieri. Roberta Mazzieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 3763: Comparative spatial analyses of the tumor immune landscape in different mouse models of glioblastoma 2024 ·Cancer Research ·(unknown), Niyati Jhaveri, Aditya Pratapa, (unknown), (unknown), (unknown), Riccardo Dolcetti, Davide Moi, Roberta Mazzieri, Theo Mantamadiotis	1
2	Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines 2023 ·Cancer Research ·(unknown), Shuxiong Chen, Linlin Ma, Roberta Mazzieri, Riccardo Dolcetti, Bernd H. A. Rehm	27
3	Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs 2023 ·Cancers ·Charlene Waryah, (unknown), Roberta Mazzieri, Riccardo Dolcetti, Erik W. Thompson, Andrew Redfern, Pilar Blancafort	3
4	Skin-Grafting and Dendritic Cell “Boosted” Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines 2023 ·Cells ·Bijun Zeng, Davide Moi, (unknown), (unknown), Ian H. Frazer, Christopher Perry, Riccardo Dolcetti, Roberta Mazzieri, Jazmina L. Gonzalez Cruz	1
5	Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma 2021 ·Nanoscale ·Taskeen Iqbal Janjua, Aria Ahmed-Cox, Anand Kumar Meka, Friederike M. Mansfeld, Helen Forgham, Rosa Mistica C. Ignacio, Yuxue Cao, Joshua A. McCarroll, Roberta Mazzieri, Maria Kavallaris, Amirali Popat	52
6	Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy 2018 ·Journal of Clinical Investigation ·Bijun Zeng, Anton P. J. Middelberg, (unknown), Kelli P. A. MacDonald, Alan G. Baxter, Meghna Talekar, Davide Moi, Kirsteen M. Tullett, Irina Caminschi, Mireille H. Lahoud, Roberta Mazzieri, Riccardo Dolcetti, Ranjeny Thomas	74
7	Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance 2018 ·Frontiers in Oncology ·(unknown), Roberta Mazzieri, Riccardo Dolcetti	139
8	B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity 2017 ·OncoImmunology ·(unknown), Zewen Kelvin Tuong, T Kobayashi, (unknown), Megan S. F. Soon, Michael Nissen, Pui Yeng Lam, Colm Keane, Frank Vari, Davide Moi, Roberta Mazzieri, Graham R. Leggatt, Maher K. Gandhi, Stephen R. Mattarollo	15
9	Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1 2015 ·Cancer Research ·Roberta Mazzieri, Giovanni Pietrogrande, (unknown), Alessandro Gandelli, Piergiuseppe Colombo, Davide Moi, Chiara Brombin, Alessandro Ambrosi, Silvio Danese, Paolo Mignatti, Francesco Blasi, Silvia D’Alessio	10
10	Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 2015 ·Cancer Cell ·Roberto Ronca, Arianna Giacomini, Emanuela Di Salle, Daniela Coltrini, Katiuscia Pagano, Laura Ragona, Sara Matarazzo, Sara Rezzola, Daniele Maiolo, Rubben Torella, Elisabetta Moroni, Roberta Mazzieri, Giulia Escobar, Marco Mor, Giorgio Colombo, Marco Presta	6
11	Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression 2014 ·OncoImmunology ·Giulia Escobar, Bernhard Gentner, Luigi Naldini, Roberta Mazzieri	18
12	Targeted genome editing in human repopulating haematopoietic stem cells breakdown → 2014 ·Nature ·Pietro Genovese, Giulia Schiroli, Giulia Escobar, Tiziano Di Tomaso, Claudia Firrito, Andrea Calabria, Davide Moi, Roberta Mazzieri, Chiara Bonini, Michael C. Holmes, Philip D. Gregory, Mirjam van der Burg, Bernhard Gentner, Eugenio Montini, Angelo Lombardo, Luigi Naldini	434
13	Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis 2008 ·Cancer Cell ·Michele De Palma, Roberta Mazzieri, Letterio S. Politi, Ferdinando Pucci, Erika Zonari, Giovanni Sitia, Stefania Mazzoleni, Davide Moi, Mary Anna Venneri, Stefano Indraccolo, Andrea Falini, Luca G. Guidotti, Rossella Galli, Luigi Naldini	235
14	Plasminogen/Plasminogen Activator and Growth Factor Activation 2007 ·Novartis Foundation symposium ·Daniel B. Rifkin, Pierre‐Emmanuel Gleizes, John G. Harpel, Irene Nunes, John S. Munger, Roberta Mazzieri, Irene Noguera	8
15	An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration 2005 ·Molecular Biology of the Cell ·Roberta Mazzieri, Silvia D’Alessio, (unknown), Liliana Ossowski, Francesco Blasi	60
16	Expression of truncated latent TGF-β-binding protein modulates TGF-β signaling 2005 ·Journal of Cell Science ·Roberta Mazzieri, Vladimir Jurukovski, Hiroto Obata, Joanne Sung, Alec B. Platt, (unknown), Nevena Karaman‐Jurukovska, Pierre‐Emmanuel Gleizes, Daniel B. Rifkin	33
17	Measurement of Active TGF-β Generated by Cultured Cells 2003 ·Humana Press eBooks ·Roberta Mazzieri, John S. Munger, Daniel B. Rifkin	18
18	Proteolytic control of growth factor availability 1999 ·Apmis ·Daniel B. Rifkin, Roberta Mazzieri, John S. Munger, Irene Noguera, Joanne Sung	131
19	Latent transforming growth factor-β: Structural features and mechanisms of activation 1997 ·Kidney International ·John S. Munger, John G. Harpel, Pierre‐Emmanuel Gleizes, Roberta Mazzieri, Irene Nunes, Daniel B. Rifkin	438
20	Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis 1995 ·Pediatric Cardiology ·Paula Rezende Camargo, R Snitcowsky, Protásio Lemos da Luz, Roberta Mazzieri, Maria de Lourdes Higuchi, Miguel Rati, Noedir Antônio Groppo Stolf, Munir Ebaid, F Pileggi	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact